FGF7, fibroblast growth factor 7, 2252

N. diseases: 167; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.010 AlteredExpression disease BEFREE Additional mRNA transcripts encoding FGF-5 and FGF-7 were expressed by RA, but not normal, synovial cells in culture. 1445445 1992
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.030 Biomarker disease BEFREE These results suggest that KGF may participate in aberrant paracrine and autocrine pathways in human pancreatic cancer. 7575607 1995
CUI: C0346647
Disease: Malignant neoplasm of pancreas
Malignant neoplasm of pancreas
0.030 Biomarker disease BEFREE These results suggest that KGF may participate in aberrant paracrine and autocrine pathways in human pancreatic cancer. 7575607 1995
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.030 Biomarker disease BEFREE The direct effect of rKGF was confirmed by demonstrating markedly increased carcinoembryonic antigen production in a human colon carcinoma cell line, LIM1899. 7962522 1994
CUI: C1153706
Disease: Endometrial adenocarcinoma
Endometrial adenocarcinoma
0.020 AlteredExpression disease BEFREE None of the five endometrial adenocarcinoma cell lines studied expressed KGF mRNA, whereas all cell lines expressed mRNA for either KGFR or FGFR-2 or for both receptors. 8243806 1993
CUI: C0027086
Disease: Myoma
Myoma
0.010 AlteredExpression disease BEFREE Human myometrium and myoma express mRNA for KGF, but not for KGFR. 8243806 1993
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.020 Biomarker group BEFREE Furthermore, KGF enhanced the DNA synthesis of the esophageal cancer cells, TE-1, in a dose-dependent manner, while the effect of bFGF was not substantial. 8275490 1994
CUI: C0152018
Disease: Esophageal carcinoma
Esophageal carcinoma
0.010 Biomarker disease BEFREE Furthermore, KGF enhanced the DNA synthesis of the esophageal cancer cells, TE-1, in a dose-dependent manner, while the effect of bFGF was not substantial. 8275490 1994
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.010 Biomarker disease BEFREE Furthermore, KGF enhanced the DNA synthesis of the esophageal cancer cells, TE-1, in a dose-dependent manner, while the effect of bFGF was not substantial. 8275490 1994
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.020 Biomarker group BEFREE These results indicate that a high proportion of breast tumors have the potential to produce aromatase and KGF, both of which could play important roles in their growth. 8499330 1993
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.040 Biomarker group BEFREE In contrast, KGF receptor transcripts were localized to the cryptal region of the mucosal epithelium in both normal and IBD tissue, with no apparent differences in the level of expression. 8566591 1996
CUI: C0000768
Disease: Congenital Abnormality
Congenital Abnormality
0.020 Biomarker group BEFREE Culturing mouse fetal lung explants in the presence of recombinant human KGF also disrupted branching morphogenesis and resulted in similar cystic malformation of the lung. 8618921 1995
CUI: C0235915
Disease: Pulmonary malformation
Pulmonary malformation
0.020 AlteredExpression disease BEFREE Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. 8618921 1995
CUI: C0010633
Disease: Cystadenoma
Cystadenoma
0.010 Biomarker disease BEFREE By embryonic day 15.5(E15.5), lungs of transgenic surfactant protein C (SP-C)-KGF mice resembled those of humans with pulmonary cystadenoma. 8618921 1995
CUI: C0302142
Disease: Deformity
Deformity
0.010 Biomarker group BEFREE Culturing mouse fetal lung explants in the presence of recombinant human KGF also disrupted branching morphogenesis and resulted in similar cystic malformation of the lung. 8618921 1995
CUI: C0000768
Disease: Congenital Abnormality
Congenital Abnormality
0.020 AlteredExpression group BEFREE Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. 8668336 1996
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.010 AlteredExpression group BEFREE Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. 8668336 1996
CUI: C1567435
Disease: Polycystic Kidney - body part
Polycystic Kidney - body part
0.010 AlteredExpression disease BEFREE Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. 8668336 1996
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.040 AlteredExpression disease BEFREE Here we demonstrate a strikingly increased expression of KGF in surgical specimens from patients suffering from Crohn's disease and ulcerative colitis. 8701991 1996
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.040 AlteredExpression group BEFREE Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. 8701991 1996
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.020 AlteredExpression disease BEFREE Here we demonstrate a strikingly increased expression of KGF in surgical specimens from patients suffering from Crohn's disease and ulcerative colitis. 8701991 1996
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.060 AlteredExpression disease BEFREE In situ hybridization studies with digoxigenin-labeled oligonucleotides (anti-sense and sense controls) were employed to examine KGF and KGF receptor mRNA expression in prostate cancer. 8759054 1995
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.060 Biomarker disease BEFREE In 10 benign prostatic hyperplasias (BPH), and in low- and high-grade prostatic carcinoma (32 total), both the KGF gene and the receptor mRNA were expressed in the glandular epithelial cells. 8759054 1995
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.020 Biomarker group BEFREE We have examined whether keratinocyte growth factor (KGF) and its receptor are expressed in normal, fetal, and prostate cancer cells since KGF may play a role in the growth of adenocarcinomas. 8759054 1995
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.100 Biomarker phenotype BEFREE As proteolysis is a prerequisite for tumor cell invasion, taken together with our previous results, the present findings suggest that KGF may play an important role in the transition of immortalized uterine cervical epithelial cells from in situ to invasive carcinoma. 8907612 1996